Augmentin Dosing for a 2-Year-Old with Sinusitis
For a 2-year-old child with sinusitis, high-dose amoxicillin-clavulanate (Augmentin) at 80-90 mg/kg/day of the amoxicillin component with 6.4 mg/kg/day of clavulanate in 2 divided doses (maximum 2g per dose) is recommended. 1
Rationale for High-Dose Augmentin in 2-Year-Olds
- Children younger than 2 years are at higher risk for harboring resistant organisms, making high-dose amoxicillin-clavulanate the preferred treatment 1
- The high-dose formulation effectively targets both β-lactamase-producing H. influenzae and M. catarrhalis as well as potentially resistant S. pneumoniae 1
- The potassium clavulanate component (6.4 mg/kg/day) provides adequate coverage against β-lactamase-producing pathogens 1
Dosing Schedule and Duration
- Administer the total daily dose in 2 divided doses 1
- Treatment should continue for 10-14 days 1
- Some guidelines suggest continuing treatment until 7 days after the patient becomes free of signs and symptoms 1
Alternative Options
- For children who cannot tolerate oral medication or who are vomiting, a single 50 mg/kg dose of ceftriaxone can be given intravenously or intramuscularly 1
- If clinical improvement is observed at 24 hours after ceftriaxone, an oral antibiotic can be substituted to complete the course 1
- For patients with penicillin allergy, second or third-generation cephalosporins may be considered, as recent evidence suggests the risk of cross-reactivity is minimal 1, 2
Monitoring Response to Treatment
- Assess clinical improvement at 3-5 days after starting treatment 1
- If no improvement is seen after 3-5 days, consider changing antibiotics or reevaluating the diagnosis 1
- Children who remain significantly febrile or symptomatic at 24 hours after parenteral therapy may require additional doses 1
Clinical Considerations and Cautions
Risk factors for resistant organisms in this 2-year-old patient include:
The high-dose amoxicillin component (80-90 mg/kg/day) achieves sinus fluid concentrations adequate to overcome resistance in S. pneumoniae 1
Gastrointestinal side effects are the most common adverse events, but twice-daily dosing may improve tolerability compared to three-times-daily regimens 3